Qube Research & Technologies LTD Paratek Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.37 - $2.54 $44,640 - $82,763
-32,584 Reduced 73.04%
12,028 $30,000
Q4 2022

Feb 14, 2023
BUY
$1.67 - $2.51 $8,099 - $12,173
4,850 Added 12.2%
44,612 $83,000
Q3 2022

Nov 14, 2022
SELL
$1.96 - $2.93 $9,186 - $13,732
-4,687 Reduced 10.54%
39,762 $102,000
Q2 2022

Aug 15, 2022
BUY
$1.73 - $3.09 $76,896 - $137,347
44,449 New
44,449 $86,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email